September 9, 2019
Sumitomo Dainippon CEO & President Hiroshi Nomura Sumitomo Dainippon Pharma is set to fork over US$3 billion upfront to gain ownership stakes in five businesses under the aegis of Roivant Sciences, with President and CEO Hiroshi Nomura confident that their...read more